Skip to content

Effect of TIVA With Magnesium Sulfate on IONM in Patients Undergoing Spine Surgery

Effect of Total Intravenous Anesthesia (TIVA) With Magnesium Sulfate on Intra-Operative Neuromonitoring (IONM) in Patients Undergoing Spine Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04716439
Enrollment
50
Registered
2021-01-20
Start date
2021-02-28
Completion date
2021-10-31
Last updated
2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine Surgery

Brief summary

Anesthesia for neurosurgery requires balancing deep and effective anesthesia as well as postoperative analgesia versus the risks of delayed recovery and postoperative respiratory depression. This randomized placebo-controlled, double-blind study was designed to evaluate the effect of magnesium sulfate on the total anesthetic and analgesic consumption using the clinical parameters in addition to the effect on IONM reading.

Detailed description

Objectives: 1. Decrease anesthetic consumption 2. Decrease use of muscle relaxants 3. Decrease analgesic consumption 4. Excellent recovery Patients & Methods: * 2 groups (total 50) Randomized Controlled Double Blind (RCDB) Study * Propofol + remifentanil + saline (Control = C group) * Propofol + remifentanil + Mgso4 (Magnesium = M group) * Adult Spine decompression and fixation After getting the Institutional Review Board (IRB) approval, This randomized controlled double blind study includes 2 groups of patients (each group 25) will be enrolled in the study. All patients undergo spine decompression and fixation surgery Induction: All patients in the study will receive iv fentanyl 2 mic/kg + propofol 2mg/kg and endotracheal intubation will be facilitated with rocuronium 0.60 mg/ kg. Then anesthesia will be maintained using total intravenous anesthesia with propofol (6-9 mg/kg/hr) + remifentanil (0.03-0.05 mic / kg/ min) Group 1 (C group) : Receive 10 mg/kg /hr 0.9% Normal Saline Group 2 (M group) : Receive 10 mg/kg/hr Magnesium Sulfate Monitoring: 1. IONM 2. train-of-four (TOF) 3. bispectral index (BIS) Measurements: 1. IO Anesthetic Consumption 2. IO Hemodynamics 3. somatosensory evoked potential (SSEP), motor evoked potential (MEP), TOF, BIS Readings 4. PO visual analogue scale (VAS) (24hours) 5. PO Morphine Consumption (24hours)

Interventions

PROCEDURESpine Surgery

spine decompression and fixation

Sponsors

King Khalid University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult Patients Undergoing Spine Surgery

Exclusion criteria

1. Renal Impairment 2. Liver Cell failure 3. Heart Block

Design outcomes

Primary

MeasureTime frameDescription
IONM Reading1- baseline 2-during surgery 3-immediately after surgeryReading the effect on the intraoperative neuromonitoring either motor or sensory evoked potential

Secondary

MeasureTime frameDescription
Morphine ConsumptionOver 24 hours postoperativeTotal morphine consumed over 24 hours in mg
Blood Pressure1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hoursSystolic, Diastolic and Mean (mmHg)
Heart Rate1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hoursbeats/min
Pain ScoreOver 24 hours postoperative11 Visual Analogue Scale (VAS) with 10 is the worst and 0 is the least

Countries

Saudi Arabia

Contacts

Primary ContactESSAM M MANAA, MD
e_manaa@yahoo.com+966509870124

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026